Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE · · 3 pages · Chinese
Release
JiangXi Tianxin Pharmaceutical Co., Ltd. on 6ix
Earlier from JiangXi Tianxin Pharmaceutical
- Annual Evaluation Report on the "Corporate Value and Return Enhancement" Action Plan 2025 and the "Corporate Value and Return Enhancement" Action Plan 2026
- Announcement on Estimated Daily Related Party Transactions in 2026
- Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
- Announcement on Operation Data for Q3 2025
- Announcement on Convening the Q3 2025 Performance Briefing
Later from JiangXi Tianxin Pharmaceutical
- Announcement on Operation Data for Q1 2026
- Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Jiangxi Jurisdiction
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Partial Completion of Canceling Special Accounts for Raised Funds
- Announcement on Implementation of Dividend Distribution for 2025
Follow JiangXi Tianxin Pharmaceutical into a list and get an email when it puts out news.
Follow JiangXi Tianxin Pharmaceutical